Single-nucleotide polymorphisms of the SLC17A9 and P2RY12 genes are significantly associated with phantom tooth pain

• Published in: Molecular pain Vol. 18; p. 17448069221089592
• Main Authors: Soeda, Moe, Ohka, Seii, Nishizawa, Daisuke, Hasegawa, Junko, Nakayama, Kyoko, Ebata, Yuko, Fukuda, Ken-ichi, Ikeda, Kazutaka
• Format: Journal Article
• Language: English
• Published: Los Angeles, CA SAGE Publications 01.01.2022; Sage Publications Ltd
• Subjects: Adenosine Triphosphate - metabolism; Alleles; ATP; Gene expression; Gene polymorphism; Genes; Humans; Microglia; Neuralgia; Nucleotide Transport Proteins - genetics; Nucleotide Transport Proteins - metabolism; Nucleotides - metabolism; Pain; Polymorphism; Polymorphism, Single Nucleotide - genetics; Receptors, Purinergic P2Y12 - genetics; Receptors, Purinergic P2Y12 - metabolism; Signal transduction; Single-nucleotide polymorphism; Spinal cord; Trigeminal ganglion; orofacial pain; solute carrier family 17 member 9; neuropathic pain; Phantom tooth pain; trigeminal nerve; vesicular nucleotide transporter; purinergic receptor P2Y12; adenosine triphosphate release
• ISSN: 1744-8069; 1744-8069
• DOI: 10.1177/17448069221089592

Phantom tooth pain (PTP) is a rare and specific neuropathic pain that occurs after pulpectomy and tooth extraction, but its cause is not understood. We hypothesized that there is a genetic contribution to PTP. We focused on solute carrier family 17 member 9 (SLC17A9)/vesicular nucleotide transporter (VNUT) and purinergic receptor P2Y12 (P2RY12), both of which have been associated with neuropathic pain and pain transduction signaling in the trigeminal ganglion in rodents. We sought to corroborate these associations in humans. We investigated gene polymorphisms that contribute to PTP. We statistically examined the association between genetic polymorphisms and PTP vulnerability in 150 patients with orofacial pain, including PTP, and 500 healthy subjects. We found that the rs735055 polymorphism of the SLC17A9 gene and rs3732759 polymorphism of the P2RY12 gene were associated with the development of PTP. Carriers of the minor allele of rs735055 and individuals who were homozygous for the major allele of rs3732759 had a higher rate of PTP. Carriers of the minor allele of rs735055 reportedly had high SLC17A9 mRNA expression in the spinal cord, which may increase the storage and release of adenosine triphosphate. Individuals who were homozygous for the major allele of rs3732759 may have higher P2RY12 expression that is more active in microglia. Therefore, these carriers may be more susceptible to PTP. These results suggest that specific genetic polymorphisms of the SLC17A9 and P2RY12 genes are involved in PTP. This is the first report on genes that are associated with PTP in humans.